神经节苷脂对脑瘫患儿疗效的Meta分析  

Meta-analysis of ganglioside treatment for children with cerebral palsy

作　　者：潘子奇[1] 刘琰[1] 郑薇[1] 张健[1] 张玉梅[1] 

机构地区：[1]北京大学公共卫生学院,北京100191

出　　处：《中国儿童保健杂志》2016年第8期842-845,共4页Chinese Journal of Child Health Care

摘　　要：目的 评价神经节苷脂对脑瘫患儿的疗效及安全性,为其临床应用提供参考。方法 检索Pubmed、Embase、Cochrane图书馆、中国生物医学文献数据库、中国期刊全文数据库及万方数字化全文期刊数据库,检索时间为建库至2015年10月。纳入有关神经节苷脂治疗脑瘫患儿的随机对照试验,对显效、有效率进行有序分类变量的Meta分析;对总有效率进行二分类变量的Meta分析;对患儿发育商评分（developmental quotient,DQ）进行连续变量的Meta分析。结果共纳入10个随机对照试验,共计806例患儿,对显效、有效率分析,其相对危险度（odds ratio,OR）为2.63,95%CI：1.95～3.53;对总有效率进行分析,其OR值为4.74,95%CI：2.99～7.52;神经节苷脂使DQ评分提高,SMD=1.30,95%CI：0.33～2.27。结论 神经节苷脂对脑瘫患儿治疗效果良好,可改善患儿的症状。Objective To evaluate the efficacy and safety of gangliosides in the treatment of children with cerebral pal- sy,to provide some evidence for its clinical application. Methods The papers related to gangliosides in the treatment of children with cerebral palsy were searched in PubMed, EMBASE, Cochrane library, CBM, CNKI, CSPD （form establish- ments to October 2015）. Randomized controlled trials on the treatment of cerebral palsy with gangliosides were included and assessed for quality. A Meta-analysis was conducted to evaluate the effectual rate and effective rate of the trials as ordinal categorical variable, to evaluate the total effective rate as binary variable, to evaluate the DQ（developmental quotient） value as continuous variable. Results A total of 10 randomized controlled trial 806 cases of children were included in the study, the OR（odds ratio） values of effectual and effective rate was 2.63 （1.95～3.53）;the OR value of total effective rate was 4.74 （2.99～7.52）;the DQ scores were increased,SMD= 1.30,95%CI=0.33～2.27. Conclusion The efficacy of gangliosides in the treatment of children with cerebral palsy is well,and the DQ value of the children are improved.

关 键 词：神经节苷脂 脑瘫 META分析 

分 类 号：R179[医药卫生—妇幼卫生保健]